Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Relevance of cerebrospinal fluid findings in patients with multiple sclerosis and seizures.

Sriwastava S, Yarraguntla K, Zutshi D, Basha MM, Bernitsas E, Marawar R.

J Neurol Sci. 2019 Nov 15;406:116482. doi: 10.1016/j.jns.2019.116482. Epub 2019 Sep 16.

PMID:
31622901
2.

Electroencephalogram Characteristics in Critical Ill Patients Before Cardiac Arrest: A Case Series.

Xu J, Mohamed W, Basha MM, Zutshi D.

Clin EEG Neurosci. 2019 Nov;50(6):423-428. doi: 10.1177/1550059419865679. Epub 2019 Jul 29.

PMID:
31353957
3.

Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature.

Renjen PN, Chaudhari DM, Shilpi US, Zutshi D, Ahmad K.

Ann Indian Acad Neurol. 2018 Oct-Dec;21(4):311-314. doi: 10.4103/aian.AIAN_411_17.

4.

Effects of Marijuana on Ictal and Interictal EEG Activities in Idiopathic Generalized Epilepsy.

Sivakumar S, Zutshi D, Seraji-Bozorgzad N, Shah AK.

J Clin Neurophysiol. 2017 Jan;34(1):e1-e4. doi: 10.1097/WNP.0000000000000332.

PMID:
27763968
5.

Alpha 3 ganglionic acetylcholine receptor antibody associated refractory status epilepticus.

Bansal P, Zutshi D, Suchdev K, Azher I, Mohamed W.

Seizure. 2016 Feb;35:1-3. doi: 10.1016/j.seizure.2015.12.008. Epub 2015 Dec 25. No abstract available.

6.

Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.

Zutshi D, Cloud LJ, Factor SA.

Tremor Other Hyperkinet Mov (N Y). 2014 Oct 23;4:266. doi: 10.7916/D8MS3R8C. eCollection 2014.

7.

Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Cloud LJ, Zutshi D, Factor SA.

Neurotherapeutics. 2014 Jan;11(1):166-76. doi: 10.1007/s13311-013-0222-5.

8.

Hypereosinophilia-an unusual cause of multiple embolic strokes and multi-organ dysfunction.

Khwaja GA, Duggal A, Kulkarni A, Choudhary N, Gupta M, Chowdhury D, Bohra V, Zutshi D.

J Clin Diagn Res. 2013 Oct;7(10):2316-8. doi: 10.7860/JCDR/2013/6004.3512. Epub 2013 Oct 5.

9.

Negative results of a phase II study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis.

Steele J, Zutshi D, Bradley WG.

Amyotroph Lateral Scler. 2007 Oct;8(5):274-5. No abstract available.

PMID:
17852024
10.

Update on bacterial conjunctivitis in South Florida.

Cavuoto K, Zutshi D, Karp CL, Miller D, Feuer W.

Ophthalmology. 2008 Jan;115(1):51-6. Epub 2007 Jun 18.

PMID:
17572497
11.

Remedial therapy after stroke: a randomised controlled trial.

Smith DS, Goldenberg E, Ashburn A, Kinsella G, Sheikh K, Brennan PJ, Meade TW, Zutshi DW, Perry JD, Reeback JS.

Br Med J (Clin Res Ed). 1981 Feb 14;282(6263):517-20.

12.
13.

Ketoprofen in rheumatoid arthritis: its tolerance and therapeutic effect.

Zutshi D, Mason M.

Scand J Rheumatol Suppl. 1976;1976(0):77-84.

PMID:
790553
14.

Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.

Dixon AJ, Davies J, Dormandy TL, Hamilton EB, Holt PJ, Mason RM, Thompson M, Weber JC, Zutshi DW.

Ann Rheum Dis. 1975 Oct;34(5):416-21.

15.

Comparison of fixed interval and visual analogue scales for rating chronic pain.

Joyce CR, Zutshi DW, Hrubes V, Mason RM.

Eur J Clin Pharmacol. 1975 Aug 14;8(6):415-20.

PMID:
1233242
16.

Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

Bucknall RC, Dixon A St J, Glick EN, Woodland J, Zutshi DW.

Br Med J. 1975 Mar 15;1(5958):600-2.

17.

Ketoprofen: double-blind cross-over study with indomethacin in patients with rheumatoid arthritis.

Zutshi DW, Stern D, Bloch M, Mason RM.

Rheumatol Rehabil. 1974 Feb;13(1):10-6. No abstract available.

PMID:
4604659
18.

Double-blind cross-over study of Orudis and placebo in fifty patients with rheumatoid arthritis.

Zutshi DW, Marr S, Bloch M, Mason RM.

Rheumatol Rehabil. 1973 May;12(2):62-7. No abstract available.

PMID:
4582347
19.

Technique of preparation of 32P beta-applicator and associated radiation safety devices for studies of radiation burns in animals.

Jain MP, Zutshi DN, Nagpal KK, Nayak NA.

Indian J Med Res. 1972 Aug;60(8):1181-5. No abstract available.

PMID:
4661468
20.

Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth.

Zutshi DW, Friedman M, Ansell BM.

Arch Dis Child. 1971 Oct;46(249):584-93. No abstract available.

21.

Comparison of three serological tests in adult rheumatoid arthritis and Still's disease (juvenile rheumatoid arthritis).

Ansell BM, Holborow J, Zutshi D, Reading A, Epstein WV.

Ann N Y Acad Sci. 1969 Dec 10;168(1):21-9. No abstract available.

PMID:
5310583
22.

FII haemagglutination test for serum antigammaglobulin factors in Still's disease.

Zutshi DW, Ansell BM, Bywaters EG, Epstein WV, Holborow EJ, Reading CA.

Ann Rheum Dis. 1969 Sep;28(5):541-7. No abstract available.

23.

FII haemagglutination test for serum antigammaglobulin factors in arthritides sero-positive and sero-negative by other tests.

Zutshi DW, Reading CA, Epstein WV, Ansell BM, Holborow EJ.

Ann Rheum Dis. 1969 May;28(3):289-99. No abstract available.

24.

Hyperparathyroidism revealed by renal biopsy.

EVANS B, ZUTSHI D.

Br Med J. 1962 Jun 23;1(5294):1739-40. No abstract available.

Supplemental Content

Loading ...
Support Center